Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Breast Cancer · Triple Negative Breast Cancer · Camrelizumab

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Henan cancer hospital, Zhengzhou, Henan, China
Contact: Study coordinator (Zhen Liu) · 18603723729

Study leads

Zhenzhen Liu
Principal Investigator
Study Principal Investigator

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Breast Cancer · Quality of Life

Abroad (travel likely)RecruitingPHASE2

Chapel Hill, United States

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.

Breast Cancer

Abroad (travel likely)RecruitingPHASE2

La Jolla, United States

ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

Triple Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Atlanta, United States · Atlanta, United States